استهداف الأعضاء الانتقائي
مراجع

↑  Cheng, Qiang; Wei, Tuo; Farbiak, Lukas; Johnson, Lindsay T.; Dilliard, Sean A.; Siegwart, Daniel J. (2020-04). "Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR–Cas gene editing". Nature Nanotechnology (بالإنجليزية). 15 (4): 313–320. DOI:10.1038/s41565-020-0669-6. ISSN:1748-3395. Archived from the original on 2022-11-23. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ= (help)
↑  Wang, Xu; Liu, Shuai; Sun, Yehui; Yu, Xueliang; Lee, Sang M.; Cheng, Qiang; Wei, Tuo; Gong, Junyu; Robinson, Joshua (2023-01). "Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery". Nature Protocols (بالإنجليزية). 18 (1): 265–291. DOI:10.1038/s41596-022-00755-x. ISSN:1750-2799. Archived from the original on 2024-05-20. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ= (help)
↑  Qiu, Min; Glass, Zachary; Chen, Jinjin; Haas, Mary; Jin, Xin; Zhao, Xuewei; Rui, Xuehui; Ye, Zhongfeng; Li, Yamin; Zhang, Feng; Xu, Qiaobing (9 Mar 2021). "Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3". Proceedings of the National Academy of Sciences (بالإنجليزية). 118 (10): e2020401118. Bibcode:2021PNAS..11820401Q. DOI:10.1073/pnas.2020401118. ISSN:0027-8424. PMC:7958351. PMID:33649229.
↑  Rhym, Luke H.; Anderson, Daniel G. (Mar 2022). "Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art". Med (بالإنجليزية). 3 (3): 167–187. DOI:10.1016/j.medj.2022.02.001. PMID:35590191. S2CID:247433557. Archived from the original on 2024-06-06.
↑  Hou, Xucheng; Zaks, Tal; Langer, Robert; Dong, Yizhou (Dec 2021). "Lipid nanoparticles for mRNA delivery". Nature Reviews Materials (بالإنجليزية). 6 (12): 1078–1094. Bibcode:2021NatRM...6.1078H. DOI:10.1038/s41578-021-00358-0. ISSN:2058-8437. PMC:8353930. PMID:34394960.
1 2  Cheng, Qiang; Wei, Tuo; Jia, Yuemeng; Farbiak, Lukas; Zhou, Kejin; Zhang, Shuyuan; Wei, Yonglong; Zhu, Hao; Siegwart, Daniel J. (Dec 2018). "Dendrimer‐Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I". Advanced Materials (بالإنجليزية). 30 (52): 1805308. Bibcode:2018AdM....3005308C. DOI:10.1002/adma.201805308. ISSN:0935-9648. PMID:30368954. S2CID:53097599. Archived from the original on 2023-02-27.
↑  Gillmore, Julian D.; Gane, Ed; Taubel, Jorg; Kao, Justin; Fontana, Marianna; Maitland, Michael L.; Seitzer, Jessica; O’Connell, Daniel; Walsh, Kathryn R.; Wood, Kristy; Phillips, Jonathan; Xu, Yuanxin; Amaral, Adam; Boyd, Adam P.; Cehelsky, Jeffrey E. (5 Aug 2021). "CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis". New England Journal of Medicine (بالإنجليزية). 385 (6): 493–502. DOI:10.1056/NEJMoa2107454. ISSN:0028-4793. PMID:34215024. S2CID:235722446. Archived from the original on 2021-12-03.
↑  Wei, Tuo; Cheng, Qiang; Min, Yi-Li; Olson, Eric N.; Siegwart, Daniel J. (26 Jun 2020). "Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing". Nature Communications (بالإنجليزية). 11 (1): 3232. Bibcode:2020NatCo..11.3232W. DOI:10.1038/s41467-020-17029-3. ISSN:2041-1723. PMC:7320157. PMID:32591530.
↑  Loughrey, David; Dahlman, James E. (4 Jan 2022). "Non-liver mRNA Delivery". Accounts of Chemical Research (بالإنجليزية). 55 (1): 13–23. DOI:10.1021/acs.accounts.1c00601. ISSN:0001-4842. PMID:34859663. S2CID:244840874. Archived from the original on 2024-03-31.
↑  Meng, Ning; Grimm, Dirk (25 May 2021). "Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR–Cas gene editing". Signal Transduction and Targeted Therapy (بالإنجليزية). 6 (1): 206. DOI:10.1038/s41392-021-00642-z. ISSN:2059-3635. PMC:8149719. PMID:34035211.
بوابة تقانة
بوابة تقانة النانو
بوابة طب